期刊文献+

HIF—1α对人肝癌细胞MDR1表达的影响 被引量:1

THE EFFECT OF HIF -1α ON MULTI -DRUG RESISTANCE IN HUMAN HEPATOCARCINOMA CELLS
下载PDF
导出
摘要 目的探讨缺氧诱导因子-1(hypoxia-inducible factors,HIF-1)α对人肝癌细胞株多药耐药基因(multi-drug resistance gene 1,MDR1)mRNA和蛋白表达的影响。方法以0、1.0、3.0、5.0μmol/L浓度的HIF-1α抑制剂YC-1和0、1.0、2.5、5.0μmol/L HIF-1α的反义寡核苷酸作用于人肝癌细胞株BEL-7402细胞,24h后RT-PCR法检测药物干预前后肝癌细胞株HIF-1、MDR1mRNA的变化;Western-Blot方法检测肝癌细胞株HIF-1、MDR1蛋白表达的变化。结果①反转录-聚合酶链反应产物结果显示,YC-1作用后,肝癌细胞HIF-1αmRNA表达差异无统计学意义,随着HIF-1α抑制剂浓度的增加,MDR1 mRNA的表达逐渐降低;随着HIF-1α反义寡核苷酸浓度的增加,HIF-1αnRNA和MDR1mRNA的表达逐渐减少,差异有统计学意义(P<0.05)。②Western-Blot检测结果显示,随着HIF-1α抑制剂浓度增加,BEL-7402细胞HIF-1α、MDR1蛋白表达逐渐减少;随着HIF-1α反义寡核苷酸浓度增加,BEL-7402细胞HIF-1α、MDR1蛋白表达亦逐渐减少。药物干预组与对照组、各浓度组比较差异有统计学意义(P<0.05)。结论 HIF-1α可以促进肝癌细胞MDR1mRNA和蛋白的表达。 Objective To investigate the regulation and influence of hypoxia inducible factor - 1 α ( HIF - 1 ) on the gene expression of multi - drug resistance genel ( MDR1 ) in human hepatocarcinoma cell lines. Methods BEL- 7402 cells were divided into control group and experiment group. The former were cultured with normal condition, the later were treated by YC - 1 , an inhibitor of HIF - 1, or the antisense oligodeoxynucleotides of HIF - 1 ( AS - ODN) with various concentration, and all of the cells were collected on time. The mRNA expressions of HIF - 1 and MDR1 in the cultured BEL -7402 cells were evaluated by reverse transcription - polymerase chain reaction and the protein levels of HIF - 1 and MDR1 in cytoplasm were evaluated by western blot. Results In human hepatocarcinoma cells, with the increasing of the concentration of YC - 1 or AS - ODN, mRNA expressions of HIF - 1 and MDR1 were decreased and the protein expressions of HIF - 1 and MDR1 were also decreased . There were significantly differences between the control and experiment groups ( P 〈 0.05 ). Conclusion HIF - 1 can promote the expression of MDR1 at the mRNA and protein levels in human hepatocarcinoma cells.
出处 《河北医科大学学报》 CAS 2011年第1期23-26,共4页 Journal of Hebei Medical University
基金 河北省卫生厅科研基金资助项目(06101)
关键词 肝细胞 P-糖蛋白 mRNA 信使 carcinoma, hepatocellular P - glycoprotein RNA, messenger
  • 相关文献

参考文献9

  • 1RANKIN EB, G1ACCIA AJ, The role of hypexia - inducible factors in tumorigenesis [ J ]. Cell Death Differ,2008,15 (4) :678 - 685.
  • 2LEE YK, KIM EJ, LEE JE, et al. Hypoxia induces connective tissue growth factor mRNA expression[ J]. J Ko - rean Med Sci, 2009, 24 (Suppl) : S 176 - S 182.
  • 3SEMENZA GL. HIF - 1 and tumor progression : pathophyslsology andtherapeutics[J] . Trends Mol Med, 2002, 8(4 Suppl) : S62 -67.
  • 4COSSE JP, MICHIELS C. Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression [ J ]. Anticancer Agents Med Chem, 2008,8 (7) : 790 -797.
  • 5高蕊,张广健,付军科,金鑫,张明鑫,李芬.分次电离辐射对食管癌细胞HIF-1α及MDR1表达的影响[J].南方医科大学学报,2010,30(5):1037-1040. 被引量:4
  • 6CHUN YS, YEO EJ, CHOI E, et al. Inhibitory effect of YC -1 on tile hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells [ J ]. Biochem Pharmacol, 2001, 61 (8): 947-954.
  • 7CHEN CJ, HSU MH, HUANG LJ, et al . Anticancer mechanisms of YC - 1 in human lung cancer cell line, NC! - H226 [ J ]. Biochemical pharmacology, 2008, 75 (2) : 360 - 368.
  • 8YEO EJ, CHUN YS, CHO YS, et al. YC -1: a potential anticancer drug targeting hypoxia - inducible factor 1 [ J]. J Natl Cancer Inst,2003, 95(7) : 516 -525.
  • 9LI SH, SHIN DH, CHUN YS, et al. A novel mode of action of YC- 1 in HIF inhibition: stimulation of FIH -dependent p300 dissociation from HIF - 1 alpha [ J ]. Mol Cancer Ther, 2008,7 (12) :3729 - 3738.

二级参考文献18

  • 1Sagar PM, Sue-Ling H, McMahon M J, et al. An audit of the treatment of cancer of the oesophagus[J]. Gut, 1994, 35: 941-5.
  • 2Unruh A, Mohamed HG, Johnson RS, et al. The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy[J]. Oncogene, 2003, 22(21): 3213-20.
  • 3Cosse JP, Michieis C. Tumour hypoxia affects the responsiveness of cancer cells to chemdflaerapy and promotes cancer progression [J]. Anticancer Agents Med Chem, 2008, 8: 790-7.
  • 4Smith TJ, Ryan LM, Douglass HO Jr, et al. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group [J]. fat J Radiat Oncol Biol Phys, 1998, 42: 269-76.
  • 5Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group[J]. JAMA, 1999, 281: 1623-7.
  • 6Kyriazis AP, Yagoda A, Kerciakes JG, et al. Experimental studies on the radiation-modifying effect of cisdiamminodichloroplatinum II (DDP) in human bladder transitional cell carcinomas grown in nude mice[J]. Cancer, 1983, 52(3): 452-7.
  • 7Henness S, Davey MW, Harvie RM, et al. Fractionated irradiation of H69 small cell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomemse II alpha expression[J]. Int J Radiat Oncol Biol Phys, 2002, 54(3): 895-902.
  • 8Ten PM, Chart AT, Lee WY, et al. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy[J]. Int J Radiat Oncol Biol Phys, 1999, 43 (2): 261-71.
  • 9Osmak M, Miljanic S, Kapitanovic S, et al. Low doses of gammarays can induce the expression of mdr gene [J]. Mutat Res, 1994, 324(1-2): 35-1.
  • 10Comerford KM, Wallace TJ, Karhausen J, et al. Hypogia-inducible factor-1-dependent regulation of the multidmg resistance (MDRI) gene[J J. Cancer Res, 2002, 62(12): 3387-94.

共引文献3

同被引文献18

  • 1檀碧波 李勇 王士杰.胃癌多药耐药机制的研究进展.河北医科大学学报,2009,:1358-1360.
  • 2Li Y, Tan BB, Zhao Q, et al. Tumor chemosensitivity is correlated with expression of multidrug resistance associated factors in variously differentiated gastric carcinoma tissues[J]. Hepatogastroenterology, 2013, 60(121):213-216.
  • 3Li Y, Tan BB, Zhao Q, et al. Regulatory mechanism of ZNFlg9 in multi-drug resistance of gastric cancer ceils[J]. Mol Biol Rep, 2014, 41(6):3603-3610.
  • 4Li Y, Tan BE, Fan LQ, etal. Heterogeneity of COX2 and multidrug resistance between primary tumors and regional lymph node metastases of gastric cancer[J]. Tumori, 2012, 98 (4) :516-522.
  • 5Chevalier F, Depagne J, Hem S, et al. Accumulation ofcyclophilin A isoforms in conditioned medium of irradiated breast cancer cells[J]. Proteomics, 2012, 12(11):1756-1766.
  • 6Zhang M, Dai C, Zhu H, et al. Cyclophilin A promotes human hepatocellular carcinoma cell metastasis via regulation of MMP3 and MMP9[J].Mol Cell Biochem, 2011, 357 (1/2) : 387-395.
  • 7Obehoei S, Weakley SM, Wongkham S, et al. Cyclophilin A enhances cell proliferation and tumor growth of liver fluke- associated cholangiocarcinoma[J]. Mol Cancer, 2011, 10 : 102.
  • 8Zhang H, Chen J, Liu F, et al. CypA, a gene downstream of HIF-la, promotes the development of PDAC[J].PLoS One, 2014, 9(3) :e92824.
  • 9Peng Y, Li X, Wu M, et al. New prognosis biomarkers identified by dynamic proteomic analysis of colorectal cancer [J]. MolBiosyst, 2012, 8(11):3077-3088.
  • 10Li Z, Min W, Gou J. Knockdown of cyclophilin A reverses paclitaxel resistance in human endometrial cancer cells via suppression of MAPK kinase pathways[J]. Cancer Chemother Pharmaeol, 2013, 72(5):1001-1011.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部